β-amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury

K. Horsburgh, G. M. Cole, F. Yang, M. J. Savage, Barry Greenberg, S. M. Gentleman, D. I. Graham, J. A R Nicoll

Research output: Contribution to journalArticle

Abstract

β-Amyloid (Aβ) deposits are found in the brains of approximately one-third of patients who die within days after a severe head injury; their presence correlating strongly with possession of an apolipoprotein E (apoE)-ε4 allele. The aim of the study was to investigate the relationship between Aβ42, Aβ40 and apoE immunostaining of Aβ plaques in the cerebral cortex and the relevance of apoE genotype in 23 fatally head-injured patients. These cases were known to have Aβ deposits from a previous study in which they were examined and semiquantified and related to apoE genotype. In the present study, the temporal cortex was probed using four different antibodies that recognize Aβ42(43), Aβ40 and an antibody to apoE. Aβ42(43)-positive plaques were observed in all of the 23 cases and Aβ40 immunoreactivity in only 11 of the 23 cases. In addition, semiquantitative analysis showed that relatively fewer plaques were detected with anti-Aβ40 than anti-Aβ42(43). ApoE-immunoreactive plaques were identified in 18 of the 23 cases. The number of plaques stained for apoE was relatively less than for Aβ42(43) but greater than for Aβ40. Furthermore, the density of AP plaques detected using either Aβ42(43), Aβ40 or apoE antibodies was associated with possession of apoE-ε4 in an allele dose-dependent manner. The results are consistent with Aβ42(43) as the initially deposited species in brain parenchyma and provide evidence that apoE is involved in the early stages of amyloid deposition. Further, the findings may be of relevance to the role of apoE genotype in influencing outcome after acute brain injury.

Original languageEnglish (US)
Pages (from-to)124-132
Number of pages9
JournalNeuropathology and Applied Neurobiology
Volume26
Issue number2
DOIs
StatePublished - Jan 1 2000
Externally publishedYes

Fingerprint

Apolipoproteins E
Craniocerebral Trauma
Amyloid
Apolipoprotein E4
Genotype
Antibodies
Alleles
Amyloid Plaques
Brain
Temporal Lobe
Cerebral Cortex
Brain Injuries
Head

Keywords

  • β-amyloid
  • Alzheimer's disease
  • Apolipoprotein E genotype
  • Head injury
  • Human
  • Immunohistochemistry

ASJC Scopus subject areas

  • Clinical Neurology
  • Pathology and Forensic Medicine
  • Neuroscience(all)

Cite this

β-amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury. / Horsburgh, K.; Cole, G. M.; Yang, F.; Savage, M. J.; Greenberg, Barry; Gentleman, S. M.; Graham, D. I.; Nicoll, J. A R.

In: Neuropathology and Applied Neurobiology, Vol. 26, No. 2, 01.01.2000, p. 124-132.

Research output: Contribution to journalArticle

Horsburgh, K. ; Cole, G. M. ; Yang, F. ; Savage, M. J. ; Greenberg, Barry ; Gentleman, S. M. ; Graham, D. I. ; Nicoll, J. A R. / β-amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury. In: Neuropathology and Applied Neurobiology. 2000 ; Vol. 26, No. 2. pp. 124-132.
@article{9123d45469924fd090cc5acb1e109b60,
title = "β-amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury",
abstract = "β-Amyloid (Aβ) deposits are found in the brains of approximately one-third of patients who die within days after a severe head injury; their presence correlating strongly with possession of an apolipoprotein E (apoE)-ε4 allele. The aim of the study was to investigate the relationship between Aβ42, Aβ40 and apoE immunostaining of Aβ plaques in the cerebral cortex and the relevance of apoE genotype in 23 fatally head-injured patients. These cases were known to have Aβ deposits from a previous study in which they were examined and semiquantified and related to apoE genotype. In the present study, the temporal cortex was probed using four different antibodies that recognize Aβ42(43), Aβ40 and an antibody to apoE. Aβ42(43)-positive plaques were observed in all of the 23 cases and Aβ40 immunoreactivity in only 11 of the 23 cases. In addition, semiquantitative analysis showed that relatively fewer plaques were detected with anti-Aβ40 than anti-Aβ42(43). ApoE-immunoreactive plaques were identified in 18 of the 23 cases. The number of plaques stained for apoE was relatively less than for Aβ42(43) but greater than for Aβ40. Furthermore, the density of AP plaques detected using either Aβ42(43), Aβ40 or apoE antibodies was associated with possession of apoE-ε4 in an allele dose-dependent manner. The results are consistent with Aβ42(43) as the initially deposited species in brain parenchyma and provide evidence that apoE is involved in the early stages of amyloid deposition. Further, the findings may be of relevance to the role of apoE genotype in influencing outcome after acute brain injury.",
keywords = "β-amyloid, Alzheimer's disease, Apolipoprotein E genotype, Head injury, Human, Immunohistochemistry",
author = "K. Horsburgh and Cole, {G. M.} and F. Yang and Savage, {M. J.} and Barry Greenberg and Gentleman, {S. M.} and Graham, {D. I.} and Nicoll, {J. A R}",
year = "2000",
month = "1",
day = "1",
doi = "10.1046/j.1365-2990.2000.026002124.x",
language = "English (US)",
volume = "26",
pages = "124--132",
journal = "Neuropathology and Applied Neurobiology",
issn = "0305-1846",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - β-amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury

AU - Horsburgh, K.

AU - Cole, G. M.

AU - Yang, F.

AU - Savage, M. J.

AU - Greenberg, Barry

AU - Gentleman, S. M.

AU - Graham, D. I.

AU - Nicoll, J. A R

PY - 2000/1/1

Y1 - 2000/1/1

N2 - β-Amyloid (Aβ) deposits are found in the brains of approximately one-third of patients who die within days after a severe head injury; their presence correlating strongly with possession of an apolipoprotein E (apoE)-ε4 allele. The aim of the study was to investigate the relationship between Aβ42, Aβ40 and apoE immunostaining of Aβ plaques in the cerebral cortex and the relevance of apoE genotype in 23 fatally head-injured patients. These cases were known to have Aβ deposits from a previous study in which they were examined and semiquantified and related to apoE genotype. In the present study, the temporal cortex was probed using four different antibodies that recognize Aβ42(43), Aβ40 and an antibody to apoE. Aβ42(43)-positive plaques were observed in all of the 23 cases and Aβ40 immunoreactivity in only 11 of the 23 cases. In addition, semiquantitative analysis showed that relatively fewer plaques were detected with anti-Aβ40 than anti-Aβ42(43). ApoE-immunoreactive plaques were identified in 18 of the 23 cases. The number of plaques stained for apoE was relatively less than for Aβ42(43) but greater than for Aβ40. Furthermore, the density of AP plaques detected using either Aβ42(43), Aβ40 or apoE antibodies was associated with possession of apoE-ε4 in an allele dose-dependent manner. The results are consistent with Aβ42(43) as the initially deposited species in brain parenchyma and provide evidence that apoE is involved in the early stages of amyloid deposition. Further, the findings may be of relevance to the role of apoE genotype in influencing outcome after acute brain injury.

AB - β-Amyloid (Aβ) deposits are found in the brains of approximately one-third of patients who die within days after a severe head injury; their presence correlating strongly with possession of an apolipoprotein E (apoE)-ε4 allele. The aim of the study was to investigate the relationship between Aβ42, Aβ40 and apoE immunostaining of Aβ plaques in the cerebral cortex and the relevance of apoE genotype in 23 fatally head-injured patients. These cases were known to have Aβ deposits from a previous study in which they were examined and semiquantified and related to apoE genotype. In the present study, the temporal cortex was probed using four different antibodies that recognize Aβ42(43), Aβ40 and an antibody to apoE. Aβ42(43)-positive plaques were observed in all of the 23 cases and Aβ40 immunoreactivity in only 11 of the 23 cases. In addition, semiquantitative analysis showed that relatively fewer plaques were detected with anti-Aβ40 than anti-Aβ42(43). ApoE-immunoreactive plaques were identified in 18 of the 23 cases. The number of plaques stained for apoE was relatively less than for Aβ42(43) but greater than for Aβ40. Furthermore, the density of AP plaques detected using either Aβ42(43), Aβ40 or apoE antibodies was associated with possession of apoE-ε4 in an allele dose-dependent manner. The results are consistent with Aβ42(43) as the initially deposited species in brain parenchyma and provide evidence that apoE is involved in the early stages of amyloid deposition. Further, the findings may be of relevance to the role of apoE genotype in influencing outcome after acute brain injury.

KW - β-amyloid

KW - Alzheimer's disease

KW - Apolipoprotein E genotype

KW - Head injury

KW - Human

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=0033625502&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033625502&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2990.2000.026002124.x

DO - 10.1046/j.1365-2990.2000.026002124.x

M3 - Article

C2 - 10840275

AN - SCOPUS:0033625502

VL - 26

SP - 124

EP - 132

JO - Neuropathology and Applied Neurobiology

JF - Neuropathology and Applied Neurobiology

SN - 0305-1846

IS - 2

ER -